Skip to main content
. Author manuscript; available in PMC: 2019 Apr 26.
Published in final edited form as: J Thorac Oncol. 2018 Mar 22;13(6):831–839. doi: 10.1016/j.jtho.2018.03.008

Figure 4.

Figure 4.

Sites of AR by pre-treatment progressing sites. Donut chart showing sites of AR (LN and/or non-LN sites; outer ring) in patients grouped by pre–PD-1 axis inhibitor sites of progression (LN and/or non-LN sites; inner circle). AR, acquired resistance; PD-1, programmed death 1; LN, lymph node.